InnovaQor, Inc. (VMCS) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
InnovaQor, Inc. (VMCS) trades at $0.0073 with AI Score 38/100 (Grade D). InnovaQor, Inc. provides IT solutions to healthcare and laboratory customers in the United States. Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for VMCS: VMCS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VMCS against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
VMCS: 2/3 scored disciplines lean bearish. Dominant signal: Jim Simons bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
InnovaQor, Inc. (VMCS) Healthcare & Pipeline Overview
InnovaQor, Inc. delivers IT solutions to the U.S. healthcare and laboratory sectors, focusing on electronic health records, laboratory information systems, and virtual CIO services. With a small team, they aim to provide tailored IT support and data analytics to improve healthcare operations, facing competition from larger, established players.
What Is the Investment Thesis for VMCS?
InnovaQor, Inc. presents a high-risk, high-reward investment opportunity within the healthcare IT sector. The company's focus on specialized EHR and LIS solutions for niche markets like behavioral health and small to mid-size labs could drive growth if effectively executed. However, the company's negative gross margin of -9.4% and profit margin of -596.5% raise concerns about its financial sustainability. Key catalysts include successful product updates and expansion of vCIO services. The ability to secure new contracts and improve operational efficiency will be critical for long-term viability. Investors should closely monitor InnovaQor's cash flow and ability to achieve profitability.
Based on FMP financials and quantitative analysis
VMCS Key Highlights
- InnovaQor, Inc. operates in the Healthcare Information Services industry, a sector experiencing growth due to increasing demand for digital health solutions.
- The company offers specialized electronic health records (EHR) for behavioral health providers and substance abuse centers, targeting a niche market.
- InnovaQor provides virtual chief information officer (vCIO) services, offering consulting and IT management to healthcare organizations.
- The company reported a negative gross margin of -9.4%, indicating challenges in controlling the cost of services.
- InnovaQor has a small team of 9 employees, suggesting a lean operational structure but also potential resource constraints.
Who Are VMCS's Competitors?
VMCS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| VEEV Veeva Systems Inc. | $179.58 | -2.69% | $29.2B | 84 |
| GEHC GE HealthCare Technologies Inc. | $61.99 | +0.94% | $28.2B | 63 |
| BTSGU BrightSpring Health Services, Inc. Tangible Equity Unit | $230.25 | +0.48% | $13.8B | 90 |
| BTSG BrightSpring Health Services, Inc. | $69.84 | +0.14% | $13.7B | 91 |
| PMCUF Pro Medicus Limited | $114.00 | -5.79% | $11.9B | 59 |
| HQY HealthEquity, Inc. | $94.33 | -1.69% | $7.89B | 93 |
| DOCS Doximity, Inc. | $20.45 | -0.20% | $3.82B | 94 |
| ONEM ONEM | $16.47 | +0.00% | $3.40B | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VMCS's Key Strengths?
- Specialized EHR and LIS solutions for niche markets.
- Integrated vCIO and IT managed services.
- Real-time data analytics and business intelligence capabilities.
- Long-standing presence in the healthcare IT market (founded in 1999).
What Are VMCS's Weaknesses?
- Negative gross and profit margins raise concerns about financial sustainability.
- Small team size (9 employees) may limit scalability.
- Limited brand recognition compared to larger competitors.
- Dependence on a small number of customers may increase revenue volatility.
What Could Drive VMCS Stock Higher?
- Potential new contracts with healthcare providers for EHR and LIS solutions.
- Expansion of vCIO services to new and existing clients.
- Development and release of new features and functionalities for existing products.
- Strategic partnerships with complementary healthcare technology companies.
- Efforts to improve operational efficiency and achieve profitability.
What Are the Key Risks for VMCS?
- Intense competition from larger, more established healthcare IT vendors.
- Cybersecurity threats and data breaches could damage reputation and erode customer trust.
- Regulatory changes in the healthcare industry may impact product compliance and market access.
- Negative gross and profit margins raise concerns about financial sustainability.
- Limited liquidity due to OTC Other listing could make it difficult to trade shares.
What Are the Growth Opportunities for VMCS?
- Expansion of vCIO Services: InnovaQor can capitalize on the growing demand for outsourced IT management in the healthcare sector by expanding its virtual chief information officer (vCIO) services. This includes offering consulting, project management, and cybersecurity solutions to healthcare organizations that lack internal IT expertise. The market for outsourced IT services in healthcare is projected to reach $87.48 billion by 2028, presenting a significant opportunity for InnovaQor to increase its revenue and market share. Timeline: Ongoing.
- Product Development and Innovation: InnovaQor can invest in developing new features and functionalities for its EHR and LIS products to meet the evolving needs of its customers. This includes incorporating artificial intelligence (AI) and machine learning (ML) technologies to improve data analytics and decision support. The global AI in healthcare market is expected to reach $95.67 billion by 2030, offering a substantial opportunity for InnovaQor to differentiate its products and attract new customers. Timeline: Ongoing.
- Strategic Partnerships and Alliances: InnovaQor can form strategic partnerships with other healthcare technology companies to expand its product offerings and reach new markets. This includes partnering with companies that offer complementary solutions, such as telehealth platforms or medical billing software. Strategic alliances can help InnovaQor to increase its competitiveness and accelerate its growth. Timeline: Ongoing.
- Geographic Expansion: InnovaQor can expand its operations beyond the United States to tap into international markets with growing demand for healthcare IT solutions. This includes targeting countries with similar healthcare systems and regulatory environments. Geographic expansion can help InnovaQor to diversify its revenue streams and reduce its reliance on the U.S. market. Timeline: 2027-2028.
- Focus on Cybersecurity Solutions: Given the increasing threat of cyberattacks in the healthcare sector, InnovaQor can focus on providing robust cybersecurity solutions to protect its customers' data and systems. This includes offering services such as vulnerability assessments, penetration testing, and security awareness training. The global healthcare cybersecurity market is projected to reach $36.5 billion by 2028, presenting a significant opportunity for InnovaQor to become a trusted provider of cybersecurity solutions. Timeline: Ongoing.
What Opportunities Does VMCS Have?
- Expansion of vCIO services to meet growing demand for outsourced IT management.
- Development of new features and functionalities for EHR and LIS products.
- Strategic partnerships with other healthcare technology companies.
- Geographic expansion to international markets.
What Threats Does VMCS Face?
- Intense competition from larger, more established healthcare IT vendors.
- Rapid technological changes may require significant investments in R&D.
- Cybersecurity threats and data breaches could damage reputation and erode customer trust.
- Regulatory changes in the healthcare industry may impact product compliance and market access.
What Are VMCS's Competitive Advantages?
- Specialized Solutions: Focus on niche markets like behavioral health and small labs provides a degree of specialization.
- Integrated Services: Offering both software and vCIO services creates a more comprehensive solution for customers.
- Data Analytics Capabilities: Real-time data analytics and business intelligence provide added value to customers.
- Established Presence: Founded in 1999, InnovaQor has an established presence in the healthcare IT market.
What Does VMCS Do?
InnovaQor, Inc., formerly known as VisualMED Clinical Solutions Corp., was founded in 1999 and is headquartered in West Palm Beach, Florida. The company develops and provides information technology solutions and services to healthcare and laboratory customers within the United States. Its core offerings include an electronic health records (EHR) product tailored for behavioral health providers and substance abuse centers, as well as a similar product designed for ambulatory practices. Additionally, InnovaQor provides a laboratory information system (LIS) product aimed at small to mid-size clinical laboratories. Beyond software solutions, InnovaQor offers business intelligence and aggregated data analytics in real-time to facilitate decision support. The company also provides virtual chief information officer (vCIO) services, encompassing life-cycle project and program management, consulting, and outsourced product design, development, enhancement, and testing services. InnovaQor's IT managed services include backups and diagnostic tools to identify security breaches and implement security policies, integrating physical surveillance and access control with cybersecurity systems. The company rebranded as InnovaQor, Inc. in September 2021, signaling a renewed focus on innovation and comprehensive IT solutions within the healthcare sector.
What Products and Services Does VMCS Offer?
- Develops electronic health records (EHR) for behavioral health providers and substance abuse centers.
- Offers EHR products for ambulatory practices.
- Provides laboratory information system (LIS) products for small to mid-size clinical laboratories.
- Develops business intelligence and aggregated data analytics for decision support.
- Offers virtual chief information officer (vCIO) services, including project management and consulting.
- Provides outsourced product design, development, enhancement, and testing services.
- Offers IT managed services, including backups and diagnostics.
- Designs and implements security policies and solutions, integrating physical and cyber security.
How Does VMCS Make Money?
- Software Licensing: Generates revenue through licensing fees for its EHR and LIS products.
- Service Fees: Earns revenue from providing vCIO services, IT managed services, and consulting.
- Data Analytics: Potentially generates revenue through the sale of aggregated data analytics and business intelligence reports.
- Project-Based Revenue: Revenue from outsourced product design, development, enhancement, and testing services.
What Industry Does VMCS Operate In?
InnovaQor, Inc. operates within the healthcare information services industry, a sector characterized by increasing demand for digital solutions driven by regulatory requirements, the need for improved patient care, and the growing adoption of telehealth. The market is competitive, with established players like ACNNF (Accenture Federal Services) and smaller, specialized firms vying for market share. InnovaQor's focus on niche markets, such as behavioral health and small to mid-size clinical laboratories, positions it to potentially capture specific segments within this broader industry. However, it faces challenges from larger competitors with greater resources and broader product offerings.
Who Are VMCS's Key Customers?
- Behavioral health providers and substance abuse centers.
- Ambulatory practices.
- Small to mid-size clinical laboratories.
- Healthcare organizations seeking vCIO and IT managed services.
InnovaQor, Inc. (VMCS) Valuation Context
Relative to its peer group, VMCS's quantitative score of 38/100 is below the peer average of 77/100.
ROE 310%Key Financial Metrics
Return on equity for InnovaQor, Inc. stands at 309.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
VMCS Financials
Bull Case vs Bear Case
Bull Case
- Specialized EHR and LIS solutions for niche markets.
- Integrated vCIO and IT managed services.
- Real-time data analytics and business intelligence capabilities.
- Long-standing presence in the healthcare IT market (founded in 1999).
Bear Case
- Negative gross and profit margins raise concerns about financial sustainability.
- Small team size (9 employees) may limit scalability.
- Limited brand recognition compared to larger competitors.
- Dependence on a small number of customers may increase revenue volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
VMCS Latest News
No recent news available for VMCS.
VMCS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VMCS.
Price Targets
Wall Street price target analysis for VMCS.
VMCS MoonshotScore
What does this score mean?
The MoonshotScore rates VMCS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Gerard Dab
CEO
Information on Gerard Dab's specific background and career history is not available in the provided data. His professional experience and educational qualifications are unknown. Further research would be needed to provide a comprehensive profile of his background.
Track Record: Due to the lack of available information on Gerard Dab's background, it is not possible to assess his track record or identify key achievements under his leadership. His strategic decisions and their impact on InnovaQor's performance cannot be evaluated based on the provided data.
VMCS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that InnovaQor, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and liquidity, and may not be required to provide regular financial reports. Investing in OTC Other stocks carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ. Investors should exercise extreme caution and conduct thorough due diligence before investing in VMCS.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The unknown disclosure status makes it difficult to assess the company's financial health.
- Low Liquidity: Limited trading volume and wide bid-ask spreads can lead to price volatility and difficulty in buying or selling shares.
- Potential for Fraud or Manipulation: The lack of regulatory oversight increases the risk of fraudulent activities or market manipulation.
- Going Concern Risk: Companies on the OTC Other tier may face financial difficulties and have a higher risk of going out of business.
- Information Asymmetry: The limited availability of information can create an uneven playing field for investors.
- Verify the company's legal registration and business licenses.
- Attempt to obtain and review any available financial statements (audited if possible).
- Research the background and experience of the company's management team.
- Check for any legal or regulatory issues involving the company or its officers.
- Assess the company's competitive position and market opportunities.
- Understand the company's business model and revenue streams.
- Evaluate the company's capital structure and debt obligations.
- Established Business: Founded in 1999, suggesting some operational history.
- Specific Product Offerings: Focus on EHR and LIS solutions indicates a defined business focus.
- Named CEO: Presence of a named CEO (Gerard Dab) provides some level of accountability.
- U.S. Based: Headquartered in West Palm Beach, Florida, providing a degree of geographic grounding.
InnovaQor, Inc. Healthcare Stock: Key Questions Answered
What does the AI Score mean for VMCS?
VMCS holds an AI Score of 38/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. InnovaQor, Inc. provides IT solutions to healthcare and laboratory customers in the United States. They offer electronic health records, laboratory information systems, business intelligence, …
What does InnovaQor, Inc. do?
InnovaQor, Inc. provides information technology solutions and services to healthcare and laboratory customers in the United States. They specialize in electronic health records (EHR) for behavioral health providers and ambulatory practices, as well as laboratory information systems (LIS) for small to mid-size clinical laboratories.
What do analysts say about VMCS stock?
As of March 18, 2026, formal analyst ratings and price targets for InnovaQor, Inc. (VMCS) are unavailable, likely due to its OTC Other listing and small market capitalization. Investors should conduct their own independent research and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions.
What are the main risks for VMCS?
InnovaQor, Inc. faces several key risks, including intense competition from larger healthcare IT vendors, the potential for cybersecurity breaches, and regulatory changes in the healthcare industry. The company's negative gross and profit margins raise concerns about its financial sustainability.
What are the key factors to evaluate for VMCS?
InnovaQor, Inc. (VMCS) holds an AI score of 38/100 (low). Not financial advice.
How frequently does VMCS data refresh on this page?
VMCS's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven VMCS's recent stock price performance?
InnovaQor, Inc. (VMCS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized EHR and LIS solutions for niche markets. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VMCS overvalued or undervalued right now?
InnovaQor, Inc. (VMCS) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research VMCS before investing?
Before investing in InnovaQor, Inc. (VMCS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on InnovaQor, Inc. due to its OTC Other listing.
- Financial data is limited, and the company's disclosure status is unknown.
- CEO background and track record are not available in the provided data.